Browse Category

NASDAQ:INM 20 November 2025 - 22 July 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

InMed Pharmaceuticals (NASDAQ:INM) climbs after $200 million Mentari infusion strengthens merger funding calculations

Shares of InMed Pharmaceuticals Inc. climbed 21% to $1.87 during late-morning trading on the Nasdaq. Mentari Therapeutics, which is merging with InMed, revealed a $200 million private placement.

22 July 2026

Biotechnology·NASDAQ:INM·Pharmaceuticals·Stock Market

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals Inc. shares slipped in early Nasdaq pre-market trading on Wednesday, giving back part of a surge sparked by its all-stock merger agreement with privately held Mentari Therapeutics and a planned $290 million financing.

20 May 2026

NASDAQ:INM·Pharmaceuticals·Stock Market

InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals Inc. is back in the spotlight today after a sharp bounce in its share price, driven by fresh preclinical data for its Alzheimer’s disease candidate INM‑901 and heavy speculative trading in the micro‑cap biotech name.

20 November 2025

Biotechnology·NASDAQ:INM·Pharmaceutical News·Stock Market

#1 STRONG BUY

Xylem

NYSE: XYL 94 / 100

#2 STRONG BUY

AerCap

NYSE: AER 92 / 100

#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100

#4 BUY

Chevron

NYSE: CVX 86 / 100

#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100

View full portfolio

Go toTop

NASDAQ:INM 20 November 2025 - 22 July 2026

InMed Pharmaceuticals (NASDAQ:INM) climbs after $200 million Mentari infusion strengthens merger funding calculations

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

TechStock² Updates

Plug Power (NASDAQ:PLUG) shares fall as cash burn comes under scrutiny following Texas sale

MARA Shares Fall Alongside Bitcoin as Lower Treasury Beta Poses Q2 Challenge

Palantir’s AI Strategy Encounters 41-Times-Sales Challenge

Standalone Medicare Part D Plans Face Heightened 2027 Churn Risk as Subsidy Ends

Trump Accounts Direct $1.5 Billion to S&P 500 ETF; Fee Impact Minimal

Top Stock Picks

Xylem

AerCap

Visa

Chevron

UPS

Live updates

Investment Disclaimer